Pacific Biosciences Of California Other Share Holders Equity 2010-2024 | PACB

Pacific Biosciences Of California other share holders equity from 2010 to 2024. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Pacific Biosciences Of California Annual Other Share Holders Equity
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
Pacific Biosciences Of California Quarterly Other Share Holders Equity
(Millions of US $)
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30 $0
2010-03-31 $0
2009-12-31
2009-09-30 $0
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.542B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $207.277B 25.29
Intuitive Surgical (ISRG) United States $191.158B 99.94
Alcon (ALC) Switzerland $43.154B 28.88
Edwards Lifesciences (EW) United States $39.233B 24.91
IQVIA Holdings (IQV) United States $38.389B 21.15
IDEXX Laboratories (IDXX) United States $35.196B 41.45
DexCom (DXCM) United States $28.330B 42.67
Waters (WAT) United States $22.897B 33.86
STERIS (STE) Ireland $21.940B 25.26
SONOVA HOLDING (SONVY) Switzerland $21.323B 0.00
Hologic (HOLX) United States $18.391B 19.41
Sysmex ADR (SSMXY) Japan $12.594B 39.49
Fresenius Medical Care AG KGaA (FMS) Germany $12.359B 12.69
Globus Medical (GMED) United States $11.177B 28.46
Penumbra (PEN) United States $9.059B 88.74
Teleflex (TFX) United States $9.009B 14.37
Masimo (MASI) United States $8.656B 41.89
Glaukos (GKOS) United States $7.898B 0.00
PROCEPT BioRobotics (PRCT) United States $4.814B 0.00
Integer Holdings (ITGR) United States $4.614B 26.15
TransMedics (TMDX) United States $3.112B 98.65
Veracyte (VCYT) United States $3.064B 91.93
Inari Medical (NARI) United States $2.972B 0.00
LivaNova (LIVN) United Kingdom $2.909B 16.80
Nihon Kohden (NHNKY) Japan $2.563B 19.47
Elekta AB (EKTAY) Sweden $2.202B 17.94
Tandem Diabetes Care (TNDM) United States $1.949B 0.00
RxSight (RXST) United States $1.800B 0.00
Integra LifeSciences Holdings (IART) United States $1.799B 9.40
Alphatec Holdings (ATEC) United States $1.294B 0.00
Artivion (AORT) United States $1.141B 75.58
OPKO Health (OPK) United States $1.092B 0.00
Pulse Biosciences (PLSE) United States $1.070B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.896B 15.23
Paragon 28 (FNA) United States $0.862B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.712B 0.00
IRadimed (IRMD) United States $0.703B 37.98
OrthoPediatrics (KIDS) United States $0.587B 0.00
Mesa Laboratories (MLAB) United States $0.585B 13.80
AxoGen (AXGN) United States $0.552B 0.00
SiBone (SIBN) United States $0.551B 0.00
Treace Medical Concepts (TMCI) United States $0.493B 0.00
Tactile Systems Technology (TCMD) United States $0.389B 21.07
Semler Scientific (SMLR) United States $0.345B 23.19
CVRx (CVRX) United States $0.345B 0.00
ClearPoint Neuro (CLPT) United States $0.302B 0.00
Delcath Systems (DCTH) United States $0.301B 0.00
AngioDynamics (ANGO) United States $0.284B 0.00
NeuroPace (NPCE) United States $0.267B 0.00
Inogen (INGN) United States $0.246B 0.00
Sight Sciences (SGHT) United States $0.202B 0.00
Accuray (ARAY) United States $0.182B 0.00
Atossa Genetics (ATOS) United States $0.172B 0.00
Nevro (NVRO) United States $0.167B 0.00
Alpha Tau Medical (DRTS) Israel $0.153B 0.00
KORU Medical Systems (KRMD) United States $0.147B 0.00
Spectral Diagnostics (EDTXF) Canada $0.114B 0.00
Sensus Healthcare (SRTS) United States $0.113B 16.78
EDAP TMS S.A (EDAP) France $0.098B 0.00
LENSAR (LNSR) United States $0.086B 0.00
WORK Medical Technology Group (WOK) China $0.084B 0.00
908 Devices (MASS) United States $0.081B 0.00
Monogram Orthopaedics (MGRM) United States $0.074B 0.00
Covalon Technologies (CVALF) Canada $0.070B 0.00
Hyperfine (HYPR) United States $0.063B 0.00
InspireMD (NSPR) Israel $0.063B 0.00
EnVVeno Medical (NVNO) United States $0.060B 0.00
Lucid Diagnostics (LUCD) United States $0.057B 0.00
Vicarious Surgical (RBOT) United States $0.054B 0.00
Rapid Micro Biosystems (RPID) United States $0.051B 0.00
Accelerate Diagnostics (AXDX) United States $0.047B 0.00
Envoy Medical (COCH) United States $0.038B 0.00
Adagio Medical Holdings (ADGM) United States $0.031B 0.00
Precision Optics (POCI) United States $0.031B 0.00
Biosig Technologies (BSGM) United States $0.030B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Spectral AI (MDAI) United States $0.026B 0.00
NexGel (NXGL) United States $0.021B 0.00
Baird Medical Investment Holdings (BDMD) $0.019B 0.00
Neuronetics (STIM) United States $0.018B 0.00
Ekso Bionics Holdings (EKSO) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.016B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Autonomix Medical (AMIX) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Pixie Dust Technologies (PXDT) Japan $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00